{"id":"W2752934452","doi":"10.2147/dddt.s133943","title":"Recent developments in the clinical pharmacology of rolapitant: subanalyses in specific populations","year":2017,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Nausea and vomiting management","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"William Osler Health System","funders":"","keywords":"Aprepitant; NK1 receptor antagonist; Chemotherapy-induced nausea and vomiting; Medicine; CYP3A4; Pharmacology; Internal medicine; Oncology; Vomiting; Substance P; Cytochrome P450; Receptor; Antiemetic","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003275006,0.0003515154,0.001600328,0.0005565486,0.0001198266,0.00003709337,0.000368641,0.0001734696,0.00005549766],"category_scores_gemma":[0.00004646081,0.0002241449,0.0001476235,0.0003600618,0.00009283521,0.00005045521,0.00006317192,0.0004327518,0.00001483138],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001108576,"about_ca_system_score_gemma":0.0005742627,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000007064929,"about_ca_topic_score_gemma":0.00001783278,"domain_scores_codex":[0.9967901,0.000695409,0.001471114,0.000438029,0.0002968317,0.0003085935],"domain_scores_gemma":[0.9985725,0.0004049604,0.000571243,0.0003306501,0.00005516949,0.00006546197],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009769524,0.0003371659,0.003765827,0.0005620525,0.0002734721,0.00008103173,0.0007061703,1.918086e-7,5.986199e-7,0.00005474921,0.001523288,0.9925978],"study_design_scores_gemma":[0.001774614,0.00004064227,0.01263225,0.002173964,0.0001355657,0.00001055968,0.00005597932,0.00000144271,0.00001186452,0.00004311976,0.9828942,0.0002257419],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001813425,0.9948154,0.00003854257,0.0002189192,0.0004318188,0.002136357,0.000001700486,0.00001236328,0.0005314364],"genre_scores_gemma":[0.0007012042,0.9948726,0.003526452,0.000164534,0.0001285417,0.0002019424,0.00007742367,0.00002985363,0.0002973928],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.992372,"threshold_uncertainty_score":0.9140365,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.5975365174808033,"score_gpt":0.5173394257454302,"score_spread":0.08019709173537304,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}